Funding · Company
CapsoVision, Inc
Saratoga, CABiotech & Pharma
CapsoVision, Inc of Saratoga, CA has disclosed $65M across 1 Form D offering filed with the SEC on Jul 23, 2024.
$65M
Total disclosed
1
Form D offering
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$65M
Form D · Jul 23, 2024 ↗
Q3 2024
· 2 amendments, first filed Mar 7, 2023
· target $65M
Filing details
HeadquartersSaratoga, CAIndustryBiotech & Pharma (Biotechnology)SEC CIK0001378325Offerings on file1
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →